Please login to the form below

Article

A glimmer of hope for Alzheimer’s patients, but at what cost?

In her latest article for PME Magazine, Rachel Howard explores the implications for P&R decisions in EU countries following the FDA’s recent approval of Aduhelm as a treatment for Alzheimer’s disease.

Read the full article here: https://bit.ly/3ikje2A

2nd August 2021

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

News:
Therapy Watch COVID-19 tracker
Research Partnership
Events:
Patient Centricity and Engagement Conference 2021
Research Partnership
Webinar:
UX beyond the website: Insights for the age of omnichannel
Research Partnership
News:
MedTech Qualitative Specialist joins Research Partnership
Research Partnership
Guide
How to embrace behavioural science principles in healthcare MR
Research Partnership
Article
A glimmer of hope for Alzheimer’s patients, but at what cost?
Research Partnership